161846 A Study on The Risk Factors of Abnormal Liver Function

Tuesday, November 6, 2007

So Hyun Park , 28 Yonkun-Dong, School of Public Health, Seoul National University, Seoul, South Korea
Shin Yi Jang , Samsung Medical Center & Cardiac and Vascular Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Seung Wook Lee , Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul, South Korea
The aim of this study is to identify the difference of the risk factors of abnormal liver function between non-obese group and obese group in Korea. We analyzed adults data aged 20yrs and older(N=5,734) from Korea Health and Nutrition Survey conducted in 2001. We defined the abnormal liver function if SGOT is over 40IU/L or SGPT is over 40IU/L. Obesity is assessed by BMI, Waist circumference, and Waist to hip ratio. Risk factors of abnormal liver function of overall subjects were investigated. Identifying obesity was a significant factor of abnormal liver function, dividing overall subjects into non-obese group and obese group, and investigated of the differences of the risk factors between the two groups, using multiple logistic regression analysis. The mean age was 45.10(±15.55). Overall abnormality rate of liver function test was 7.8%. In the non-obese group, gender, HbsAg, alcohol, and drug showed high odds ratios. While in the obese group, gender, exercise, and diet control showed high odds ratios for abnormal liver function. Obesity is the leading cause of abnormal liver function, and obese subjects differ from non-obese subjects in association with abnormal liver function. We suggest that in obese subjects, exercise and diet control is the first consideration to prevent abnormal liver function.

Learning Objectives:
The aim of this study is to identify the difference of the risk factors of abnormal liver function between non-obese group and obese group in Korea.

Keywords: Nutrition, Obesity

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.